Difference between revisions of "Interferon alfa-2b (Intron-A)"
(updated content) |
|||
| Line 11: | Line 11: | ||
*[[Melanoma]] | *[[Melanoma]] | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
| + | *[[Neuroendocrine tumors]] | ||
*[[Transplant conditioning regimens]] | *[[Transplant conditioning regimens]] | ||
Revision as of 14:57, 25 June 2013
Also known as (caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a): Advaferon, Alfaferone, Berofor, Biogamma, Canferon A, Cytoferon, Egiferon, Feron, Fiblaferon, Frone, Finnferon-Alpha, Heberon Alfa R, Humoferon, IFN Alpha, Imufor, Imukin, INF, Inferax, Infergen, Inmutag, Interfero, Interferon Alfanative, Interferon Human, Interferon Leucocyticum, Interferon Lymphoblastoid, Interferonum Leucocyticum, Laroferon, Multiferon, Namalvin, OIF, Polyferon, Realdiron, Roceron-A, Sumiferon, or Wellferon.
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.[1][2][3]
Route: SC, IM, IV, intralesional
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Interferon alfa-2b (Intron-A) patient drug information (Chemocare)[4]
- Interferon alfa-2b (Intron-A) patient drug information (UpToDate)[5]